GAMMA Investing’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$106K Buy
1,526
+305
+25% +$18.2K ﹤0.01% 1841
2026
Q2
$54.5K Buy
1,221
+561
+85% +$26.6K ﹤0.01% 2242
2026
Q1
$34K Sell
660
-296
-31% -$20.7K ﹤0.01% 2435
2025
Q4
$88.2K Buy
956
+691
+261% +$66.1K ﹤0.01% 1672
2025
Q3
$19.7K Sell
265
-359
-58% -$36.3K ﹤0.01% 2524
2025
Q2
$81K Buy
624
+51
+9% +$7.39K 0.01% 1596
2025
Q1
$91.3K Buy
573
+411
+254% +$74.4K 0.01% 1339
2024
Q4
$30K Sell
162
-16
-9% -$3.11K ﹤0.01% 2035
2024
Q3
$37.6K Buy
178
+151
+559% +$26.2K ﹤0.01% 1694
2024
Q2
$3.61K Sell
27
-14
-34% -$2.65K ﹤0.01% 2681
2024
Q1
$8.81K Buy
41
+23
+128% +$4.51K ﹤0.01% 2130
2023
Q4
$3.8K Buy
+18
New +$2.92K ﹤0.01% 2350

Other funds holding INSP

GAMMA Investing's INSP Position: Q3 2026 in Review

GAMMA Investing increased its Inspire Medical Systems (INSP) stake by 25% in Q3 2026, buying an estimated $18.2K and bringing the position to 1,526 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #1841.

GAMMA Investing first reported a position in INSP in Q4 2023 and has held it in 12 quarters since. 10 funds tracked by Wall St. Rank hold INSP as of Q3 2026.

  • GAMMA Investing held 1,526 shares of Inspire Medical Systems worth $106K as of Q3 2026.
  • GAMMA Investing bought 305 Inspire Medical Systems shares in Q3 2026, an estimated $18.2K.
  • Inspire Medical Systems made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #1841 holding.
  • GAMMA Investing first reported a position in Inspire Medical Systems in Q4 2023 and has held it in 12 quarters since.
  • 10 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.